Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 4, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-03-25
DOI
10.3389/fonc.2014.00054
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031
- (2014) K R Schultz et al. LEUKEMIA
- Nilotinib treatment-associated cerebrovascular disease and stroke
- (2013) Elizabeth A. Coon et al. AMERICAN JOURNAL OF HEMATOLOGY
- Phase II trial of HyperCVAD and Dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemia
- (2013) Ohad Benjamini et al. AMERICAN JOURNAL OF HEMATOLOGY
- Molecular aspects of cancer cell resistance to chemotherapy
- (2013) Magali Rebucci et al. BIOCHEMICAL PHARMACOLOGY
- Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy
- (2013) B. Boyerinas et al. BLOOD
- High-resolution melting analyses for genetic variants in ARID5B and IKZF1 with childhood acute lymphoblastic leukemia susceptibility loci in Taiwan
- (2013) Chien-Yu Lin et al. BLOOD CELLS MOLECULES AND DISEASES
- Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia
- (2013) Erich Piovan et al. CANCER CELL
- Mammalian target of rapamycin inhibitor rapamycin enhances anti-leukemia effect of imatinib on Ph+acute lymphoblastic leukemia cells
- (2013) Xi Yang et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia
- (2013) A. Caye et al. HAEMATOLOGICA
- Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia
- (2013) A. Bokemeyer et al. HAEMATOLOGICA
- Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features
- (2013) C. J. Schwab et al. HAEMATOLOGICA
- Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia
- (2013) Maria E. Figueroa et al. JOURNAL OF CLINICAL INVESTIGATION
- Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia: Results of the CA180-018 Phase I Dose-Escalation Study of the Innovative Therapies for Children With Cancer Consortium
- (2013) C. Michel Zwaan et al. JOURNAL OF CLINICAL ONCOLOGY
- Tyrosine Kinase Inhibitor Therapy Induces Remission in a Patient With Refractory EBF1-PDGFRB–Positive Acute Lymphoblastic Leukemia
- (2013) Brent W. Weston et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel Susceptibility Variants at 10p12.31-12.2 for Childhood Acute Lymphoblastic Leukemia in Ethnically Diverse Populations
- (2013) Heng Xu et al. JNCI-Journal of the National Cancer Institute
- Relapsed childhood acute lymphoblastic leukaemia
- (2013) Deepa Bhojwani et al. LANCET ONCOLOGY
- Nilotinib treatment-associated accelerated atherosclerosis: when is the risk justified?
- (2013) A Tefferi LEUKEMIA
- ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group
- (2013) Amy M. Linabery et al. LEUKEMIA RESEARCH
- The genomic landscape of hypodiploid acute lymphoblastic leukemia
- (2013) Linda Holmfeldt et al. NATURE GENETICS
- A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia
- (2013) Sohela Shah et al. NATURE GENETICS
- A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias
- (2013) J.E. Cortes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Small Molecule ErbB Inhibitors Decrease Proliferative Signaling and Promote Apoptosis in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
- (2013) Mary E. Irwin et al. PLoS One
- The Basic Principles of Chimeric Antigen Receptor Design
- (2013) Michel Sadelain et al. Cancer Discovery
- Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group Study
- (2012) I.-M. Chen et al. BLOOD
- Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project
- (2012) M. L. Loh et al. BLOOD
- Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia
- (2012) T. Bhatla et al. BLOOD
- Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia
- (2012) S. L. Maude et al. BLOOD
- Imatinib resistant BCR-ABL1 mutations at relapse in children with Ph+ALL: a Children's Oncology Group (COG) study
- (2012) Bill H. Chang et al. BRITISH JOURNAL OF HAEMATOLOGY
- Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
- (2012) Kathryn G. Roberts et al. CANCER CELL
- Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in mice
- (2012) Robert Welschinger et al. EXPERIMENTAL HEMATOLOGY
- Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains
- (2012) J. J. Trowbridge et al. GENES & DEVELOPMENT
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II study
- (2012) Kensuke Usuki et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia
- (2012) Huan Chen et al. Journal of Hematology & Oncology
- Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study
- (2012) Andrea Biondi et al. LANCET ONCOLOGY
- Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome—positive acute lymphoblastic leukemia
- (2012) O G Ottmann et al. LEUKEMIA
- Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations
- (2012) A Dupuis et al. LEUKEMIA
- Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia
- (2012) H Pfeifer et al. LEUKEMIA
- Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia
- (2012) S Krentz et al. LEUKEMIA
- Cell of origin determines clinically relevant subtypes of MLL-rearranged AML
- (2012) A V Krivtsov et al. LEUKEMIA
- Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia
- (2012) H Pfeifer et al. LEUKEMIA
- IKAROS Deletions Dictate a Unique Gene Expression Signature in Patients with Adult B-Cell Acute Lymphoblastic Leukemia
- (2012) Ilaria Iacobucci et al. PLoS One
- Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies
- (2012) David Barrett et al. PEDIATRIC DRUGS
- Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells
- (2011) R. Gioia et al. BLOOD
- ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling
- (2011) L. Kuster et al. BLOOD
- Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC
- (2011) R. Nahar et al. BLOOD
- Developmental origins and impact of BCR-ABL1 fusion and IKZF1 deletions in monozygotic twins with Ph+ acute lymphoblastic leukemia
- (2011) G. Cazzaniga et al. BLOOD
- Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies
- (2011) L. E. Hogan et al. BLOOD
- Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group
- (2011) J. Zhang et al. BLOOD
- Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
- (2011) R. Foa et al. BLOOD
- Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL): results of the Spanish Cooperative G
- (2011) Susana Rives et al. BRITISH JOURNAL OF HAEMATOLOGY
- CDKN2A/B Alterations Impair Prognosis in Adult BCR-ABL1-Positive Acute Lymphoblastic Leukemia Patients
- (2011) I. Iacobucci et al. CLINICAL CANCER RESEARCH
- Mutations and Deletions of the TP53 Gene Predict Nonresponse to Treatment and Poor Outcome in First Relapse of Childhood Acute Lymphoblastic Leukemia
- (2011) Jana Hof et al. JOURNAL OF CLINICAL ONCOLOGY
- Pediatric Phase I Trial and Pharmacokinetic Study of Dasatinib: A Report From the Children's Oncology Group Phase I Consortium
- (2011) Richard Aplenc et al. JOURNAL OF CLINICAL ONCOLOGY
- BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia
- (2011) Christian Hurtz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Ebf1orPax5haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia
- (2011) Lynn M. Heltemes-Harris et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Regulation of mammalian target of rapamycin and mitogen activated protein kinase pathways by BCR–ABL
- (2011) Amanda J. Redig et al. LEUKEMIA & LYMPHOMA
- Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population
- (2011) Agata Pastorczak et al. LEUKEMIA RESEARCH
- Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells
- (2011) Faiyaz Notta et al. NATURE
- CREBBP mutations in relapsed acute lymphoblastic leukaemia
- (2011) Charles G. Mullighan et al. NATURE
- BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition
- (2011) Cihangir Duy et al. NATURE
- Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells
- (2011) Barthelemy Diouf et al. NATURE MEDICINE
- Stem cell gene expression programs influence clinical outcome in human leukemia
- (2011) Kolja Eppert et al. NATURE MEDICINE
- AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo
- (2011) M Yu et al. Blood Cancer Journal
- Uncommon BCR-ABL kinase domain mutations in kinase inhibitor-resistant chronic myelogenous leukemia and Ph+ acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effects
- (2010) D. Jones et al. BLOOD
- First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia
- (2010) F. Ravandi et al. BLOOD
- A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo
- (2010) Leandro C. Cerchietti et al. CANCER CELL
- STAT5 in B cell development and leukemia
- (2010) Stephen Malin et al. CURRENT OPINION IN IMMUNOLOGY
- From hematopoietic progenitors to B cells: mechanisms of lineage restriction and commitment
- (2010) Julita Ramírez et al. CURRENT OPINION IN IMMUNOLOGY
- The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party
- (2010) I. Iacobucci et al. HAEMATOLOGICA
- Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis
- (2010) S. Soverini et al. HAEMATOLOGICA
- Association of a Leukemic Stem Cell Gene Expression Signature With Clinical Outcomes in Acute Myeloid Leukemia
- (2010) Andrew J. Gentles JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Expression of a Src Family Kinase in Chronic Myelogenous Leukemia Cells Induces Resistance to Imatinib in a Kinase-dependent Manner
- (2010) Teodora Pene-Dumitrescu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clinical Outcome of Children With Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005
- (2010) Maurizio Aricò et al. JOURNAL OF CLINICAL ONCOLOGY
- Janus kinase 2 regulates Bcr–Abl signaling in chronic myeloid leukemia
- (2010) A Samanta et al. LEUKEMIA
- Inhibition of Grb2 expression demonstrates an important role in BCR–ABL-mediated MAPK activation and transformation of primary human hematopoietic cells
- (2010) H Modi et al. LEUKEMIA
- IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL
- (2010) R P Kuiper et al. LEUKEMIA
- Ikaros and Aiolos Inhibit Pre-B-Cell Proliferation by Directly Suppressing c-Myc Expression
- (2010) S. Ma et al. MOLECULAR AND CELLULAR BIOLOGY
- Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors
- (2010) Jianming Zhang et al. NATURE
- Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk
- (2010) Amy L Sherborne et al. NATURE GENETICS
- Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
- (2010) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
- (2010) Giuseppe Saglio et al. NEW ENGLAND JOURNAL OF MEDICINE
- Imatinib mesylate in children and adolescents with cancer
- (2010) Ronald D. Barr PEDIATRIC BLOOD & CANCER
- Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy
- (2010) Susan L. Hobernicht et al. PEDIATRIC BLOOD & CANCER
- Second-Generation Tyrosine Kinase Inhibitors in the Post-Transplant Period in Patients with Chronic Myeloid Leukemia or Philadelphia-Positive Acute Lymphoblastic Leukemia
- (2009) Evgeny Klyuchnikov et al. ACTA HAEMATOLOGICA
- Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph-positive acute lymphoblastic leukemia who failed imatinib: Results from a phase 3 study
- (2009) Michael B. Lilly et al. AMERICAN JOURNAL OF HEMATOLOGY
- Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood
- (2009) R. B. Prasad et al. BLOOD
- Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP)
- (2009) I. Iacobucci et al. BLOOD
- Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia patients
- (2009) M J Burke et al. BONE MARROW TRANSPLANTATION
- AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
- (2009) Thomas O'Hare et al. CANCER CELL
- Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study
- (2009) Miyoung Kim et al. CANCER GENETICS AND CYTOGENETICS
- Cytogenetics and Molecular Genetics of Acute Lymphoblastic Leukemia
- (2009) Krzysztof Mrózek et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Genome-wide Lineage-Specific Transcriptional Networks Underscore Ikaros-Dependent Lymphoid Priming in Hematopoietic Stem Cells
- (2009) Samuel Yao-Ming Ng et al. IMMUNITY
- IKZF1(Ikaros) Deletions inBCR-ABL1–Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report
- (2009) Giovanni Martinelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
- (2009) Kirk R. Schultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Oligomerization inhibition, combined with allosteric inhibition, abrogates the transformation potential of T315I-positive BCR/ABL
- (2009) A A Mian et al. LEUKEMIA
- PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study
- (2009) J Familiades et al. LEUKEMIA
- Germline genomic variants associated with childhood acute lymphoblastic leukemia
- (2009) Lisa R Treviño et al. NATURE GENETICS
- DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction
- (2009) Ann-Marie Bröske et al. NATURE GENETICS
- Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia
- (2009) Elli Papaemmanuil et al. NATURE GENETICS
- Acute Lymphoblastic Leukemia — On the Wings of IKAROS
- (2009) Katia Georgopoulos NEW ENGLAND JOURNAL OF MEDICINE
- Deletion ofIKZF1and Prognosis in Acute Lymphoblastic Leukemia
- (2009) Charles G. Mullighan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The cytotoxicity of a Grb2-SH3 inhibitor in Bcr-Abl positive K562 cells
- (2008) Yun-Bin Ye et al. BIOCHEMICAL PHARMACOLOGY
- Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells
- (2008) J. Wu et al. BLOOD
- Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance
- (2008) I. Iacobucci et al. BLOOD
- BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome-positive leukemias
- (2008) D. Jones et al. BLOOD
- Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia
- (2008) K. Porkka et al. BLOOD
- Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia
- (2008) J. J. Yang et al. BLOOD
- A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo
- (2008) L. C. Cerchietti et al. BLOOD
- Allo-hematopoietic cell transplantation for Ph chromosome-positive ALL: impact of imatinib on relapse and survival
- (2008) M J Burke et al. BONE MARROW TRANSPLANTATION
- Kinase domain point mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia emerge after therapy with BCR-ABL kinase inhibitors
- (2008) Dan Jones et al. CANCER
- Evidence that Resistance to Nilotinib May Be Due to BCR-ABL, Pgp, or Src Kinase Overexpression
- (2008) F.-X. Mahon et al. CANCER RESEARCH
- Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL
- (2008) C. G. Mullighan et al. GENES & DEVELOPMENT
- E2A Proteins Promote Development of Lymphoid-Primed Multipotent Progenitors
- (2008) Sheila Dias et al. IMMUNITY
- Targeting of the N-terminal coiled coil oligomerization interface by a helix-2 peptide inhibits unmutated and imatinib-resistant BCR/ABL
- (2008) Tim Beissert et al. INTERNATIONAL JOURNAL OF CANCER
- Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells
- (2008) Michael G. Kharas et al. JOURNAL OF CLINICAL INVESTIGATION
- Activity of Bosutinib, Dasatinib, and Nilotinib Against 18 Imatinib-Resistant BCR/ABL Mutants
- (2008) Sara Redaelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Association Between Imatinib-Resistant BCR-ABL Mutation-Negative Leukemia and Persistent Activation of LYN Kinase
- (2008) Ji Wu et al. JNCI-Journal of the National Cancer Institute
- BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
- (2008) Charles G. Mullighan et al. NATURE
- The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells
- (2008) Stephen J Loughran et al. NATURE IMMUNOLOGY
- An inhibitor-resistant mutant of Hck protects CML cells against the antiproliferative and apoptotic effects of the broad-spectrum Src family kinase inhibitor A-419259
- (2008) T Pene-Dumitrescu et al. ONCOGENE
- Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
- (2008) C. G. Mullighan et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started